| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
42,197
|
30,912
|
41,492
|
39,224
| | Cost of Revenue | 2,912 | 3,379 | 3,769 | 4,013 | | |
Gross Profit
|
-
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 23,025 | 25,568 | 23,433 | 23,225 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 11,348 | 44,804 | 7,297 | 6,690 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
-
|
-
|
-
|
-
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 4,912 | (42,839) | 6,993 | 5,296 |
|
Interest Expense | 256 | 381 | 447 | 490 |
|
Income Before Tax | 4,656 | (43,220) | 6,546 | 4,806 |
|
Income Tax Expense | 1,556 | (17,283) | 2,123 | 1,516 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 3,100 | (25,937) | 4,423 | 3,290 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
3,100
|
(25,937)
|
4,423
|
3,290
| | Preferred Stock And Other Adjustments | (245) | (532) | (688) | (829) | | |
Net Income Applicable To Common Shares
|
2,855
|
(26,469)
|
3,735
|
2,461
|
|
0.16(1.15%) 10:16AM EDT - Nasdaq Real Time Price